| Literature DB >> 34298898 |
Vesna Rastija1, Karolina Vrandečić1, Jasenka Ćosić1, Ivana Majić1, Gabriella Kanižai Šarić1, Dejan Agić1, Maja Karnaš1, Melita Lončarić2, Maja Molnar2.
Abstract
The aim was to study the inhibitory effects of coumarin derivatives on the plant pathogenic fungi, as well as beneficial bacteria and nematodes. The antifungal assay was performed on four cultures of phytopathogenic fungi by measuring the radial growth of the fungal colonies. Antibacterial activity was determined by the broth microdilution method performed on two beneficial soil organisms. Nematicidal activity was tested on two entomopathogenic nematodes. The quantitative structure-activity relationship (QSAR) model was generated by genetic algorithm, and toxicity was estimated by T.E.S.T. software. The mode of inhibition of enzymes related to the antifungal activity is elucidated by molecular docking. Coumarin derivatives were most effective against Macrophomina phaseolina and Sclerotinia sclerotiorum, but were not harmful against beneficial nematodes and bacteria. A predictive QSAR model was obtained for the activity against M. phaseolina (R2tr = 0.78; R2ext = 0.67; Q2loo = 0.67). A QSAR study showed that multiple electron-withdrawal groups, especially at position C-3, enhanced activities against M. phaseolina, while the hydrophobic benzoyl group at the pyrone ring, and -Br, -OH, -OCH3, at the benzene ring, may increase inhibition of S. sclerotiourum. Tested compounds possibly act inhibitory against plant wall-degrading enzymes, proteinase K. Coumarin derivatives are the potentially active ingredient of environmentally friendly plant-protection products.Entities:
Keywords: QSAR; antibacterial activity; antifungal activity; coumarin derivatives; molecular docking; nematicidal activity; plant protection; toxicity
Mesh:
Substances:
Year: 2021 PMID: 34298898 PMCID: PMC8303553 DOI: 10.3390/ijms22147283
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Structures of analyzed compounds.
|
| ||
|---|---|---|
| No. mol | Mol ID | Substituents |
|
|
| 3-COOC2H5 |
|
|
| 3-COC6H5 |
|
|
| 3-COC6H5; 7-OCH2C6H5 |
|
|
| 3-COOC2H5; 6-Br |
|
|
| 3-COOCH3; 6-OH |
|
|
| 3-COOC2H5; 6-OH |
|
|
| 3-COOC2H5; 6-Cl |
|
|
| 3-COC6H5; 6-Br; 8-Br |
|
|
| 3-COOCH3; 7-OCH3 |
|
|
| 3-COOC2H5; 7-OCH3 |
|
|
| 3-COOCH3; 6-OCH3 |
|
|
| 3-COOC2H5; 8-OC2H5 |
|
|
| 3-COC6H5; 8-OC2H5 |
|
|
| 3-COOCH3; 6-N+OO− |
|
|
| 3-COOC2H5; 6-N+OO− |
|
|
| 3-COCH3 |
|
|
| 3-CN |
|
|
| 3-COCH3; 8-OH |
|
|
| 3-CN; 8-OH |
|
|
| 3-COCH3; 7-OH |
|
|
| 3-COCH3; 7-N(C2H5)2 |
|
|
| 3-COCH3; 6-Br |
|
|
| 3-CN; 6-Br |
|
|
| 3-COCH3; 6-OH |
|
|
| 3-CN; 6-OH |
|
|
| 3-CN; 7-OCH3 |
|
|
| 3-CN; 6-OCH3 |
|
|
| 3-COCH3; 8-OC2H5 |
|
|
| 3-CN; 8-OC2H5 |
|
|
| 3-COOCH3 |
|
|
| 3-CN; 7-OCH2C6H5 |
|
|
| 3-COOCH3; 7-OH |
|
|
| 3-COC6H5; 7-OH |
|
|
| 3-COOCH3; 6-Br |
|
|
| 3-COC6H5; 6-Cl |
|
|
| 3-COC6H5; 7-OCH3 |
|
|
| 3-COC6H5; 6-OH |
|
|
| 3-COOC2H5; 6-Br; 8-Br |
Results of antifungal, antibacterial and nematicidal activity of 38 coumarin derivatives. (a inhibition rate %, 48 h after inoculation at the concentration 0.08 μmol/mL; b minimum inhibitory concentration (MIC/μg mL−1); c percentage corrected mortality, %, 48 h after inoculation at the concentration 500 μg/mL).
| Antifungal Activity a | Antibacterial Activity b | Nematicidal Activity c | ||||||
|---|---|---|---|---|---|---|---|---|
| No. mol |
|
|
|
|
|
|
| |
|
| 53.63 | 73.09 | −3.64 | −9.53 | >512 | >512 | 8.00 | 10.00 |
|
| 57.67 | 39.62 | 1.21 | −8.67 | >512 | >512 | 29.75 | 18.75 |
|
| 53.63 | 64.89 | 4.85 | −7.80 | >512 | >512 | 0.00 | 0.00 |
|
| 56.52 | 77.87 | 1.21 | −0.87 | >512 | >512 | 0.00 | 3.75 |
|
| 64.01 | 76.50 | −6.07 | −6.07 | >512 | 64 | 0.00 | 0.00 |
|
| 66.32 | 82.65 | 14.56 | 26.86 | >512 | >512 | 31.25 | 20.75 |
|
| 65.74 | 84.02 | 10.92 | 13.86 | >512 | 512 | 0.00 | 0.00 |
|
| 66.32 | 84.70 | 13.35 | 6.93 | >512 | >512 | 0.00 | 0.00 |
|
| 74.39 | 84.70 | 13.35 | 10.40 | >512 | 512 | 0.00 | 0.00 |
|
| 72.09 | 64.89 | 19.42 | 13.86 | >512 | >512 | 56.75 | 64.00 |
|
| 53.06 | 51.91 | 6.07 | −6.93 | >512 | >512 | 0.00 | 4.25 |
|
| 69.78 | 59.43 | −7.28 | −27.73 | >512 | >512 | 24.75 | 21.00 |
|
| 24.80 | 67.62 | −6.07 | −32.93 | >512 | >512 | 0.00 | 0.00 |
|
| 55.94 | 81.97 | −10.92 | −4.33 | >512 | 512 | 0.00 | 0.00 |
|
| 59.98 | 76.50 | 0.00 | −6.93 | >512 | 512 | 0.00 | 2.00 |
|
| 61.71 | 43.72 | 27.91 | 30.33 | >512 | >512 | 0.00 | 0.00 |
|
| 61.71 | 38.93 | 23.06 | 26.00 | >512 | >512 | 8.75 | 14.75 |
|
| 59.98 | 27.32 | 27.91 | 9.53 | >512 | >512 | 0.00 | 0.00 |
|
| 69.78 | 54.64 | 32.77 | 13.00 | 512 | >512 | 20.75 | 11.25 |
|
| 65.74 | 4.78 | 29.13 | −3.47 | 512 | >512 | 5.50 | 17.00 |
|
| 74.97 | 40.98 | 40.05 | 26.00 | >512 | >512 | 13.00 | 22.50 |
|
| 70.36 | 43.72 | 29.13 | 33.80 | >512 | >512 | 0.00 | 0.00 |
|
| 83.62 | −15.03 | 27.91 | −9.53 | >512 | >512 | 0.00 | 2.75 |
|
| 80.16 | 55.33 | 64.32 | 70.19 | >512 | >512 | 44.50 | 43.00 |
|
| 74.39 | 54.64 | 66.75 | 62.39 | >512 | >512 | 0.00 | 1.25 |
|
| 72.66 | 23.91 | 40.05 | 45.06 | 512 | >512 | 12.00 | 14.25 |
|
| 75.55 | 61.48 | 71.60 | 63.26 | 512 | 512 | 0.00 | 0.00 |
|
| 76.12 | 79.92 | 65.53 | 65.86 | >512 | >512 | 0.00 | 0.00 |
|
| 77.28 | 66.26 | 65.53 | 70.19 | >512 | >512 | 0.00 | 0.00 |
|
| 70.93 | −7.51 | 20.63 | −17.33 | >512 | >512 | 0.00 | 0.00 |
|
| 69.20 | 0.68 | 32.77 | −1.73 | >512 | >512 | 0.00 | 0.00 |
|
| 79.58 | −4.10 | 24.27 | −11.27 | >512 | >512 | 17.50 | 10.50 |
|
| 68.63 | 6.83 | 27.91 | −10.40 | >512 | >512 | 0.00 | 10.50 |
|
| 66.90 | −15.71 | 27.91 | −10.40 | >512 | >512 | 16.50 | 40.25 |
|
| 78.43 | −26.64 | 35.19 | 6.93 | >512 | >512 | 0.00 | 0.00 |
|
| 79.01 | 51.91 | 44.90 | 23.40 | >512 | >512 | 0.00 | 9.00 |
|
| 64.01 | 13.66 | 31.55 | 0.00 | >512 | >512 | 0.00 | 4.75 |
|
| 80.16 | 10.25 | 35.19 | 1.73 | >512 | >512 | 0.00 | 0.00 |
|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Estimated toxicity for 38 coumarin derivatives.
| No. mol | Oral Rat LD50 | Fathead Minnow pLC50 96-h (mol/L) c | Mutagenicity Value (Result) d | Bioaccumulation (logBAF/L kg−1) e | |
|---|---|---|---|---|---|
|
| 978.2 | 4.03 | 4.59 | 0.45 (neg) | 0.85 |
|
| 386.97 | 4.97 | 5.68 | 0.43 (neg) | 1.52 |
|
| 147.37 | 5.86 | 7.12 | 0.18 (neg) | 1.48 |
|
| 2223.31 | 4.66 | 5.24 | 0.14 (neg) | 1.14 |
|
| 1146.8 | 4.37 | 4.43 | 0.28 (neg) | 0.79 |
|
| 1592.38 | 4.15 | 4.78 | 0.36 (neg) | 0.76 |
|
| 1251.57 | 4.54 | 5.08 | 0.26 (neg) | 1.31 |
|
| 634.37 | 5.87 | 6.82 | 0.35 (neg) | 2.09 |
|
| 1882.79 | 3.96 | 4.29 | 0.49 (neg) | 0.68 |
|
| 2471.53 | 4.37 | 4.66 | 0.45 (neg) | 0.77 |
|
| 975.12 | 3.74 | 4.52 | 0.44 (neg) | 1.03 |
|
| 2358.27 | 4.14 | 5.07 | 0.45 (neg) | 1.12 |
|
| 387.72 | 4.74 | 5.64 | 0.40 (neg) | 1.42 |
|
| 1799.19 | 4.18 | 4.93 | 0.63 (pos) | 0.45 |
|
| 1169.36 | 4.78 | 5.20 | 0.61 (pos) | 0.48 |
|
| 774.04 | 5.01 | 4.27 | 0.03 (neg) | 0.90 |
|
| 519.66 | 4.37 | 3.74 | 0.36 (neg) | 1.24 |
|
| 1163.28 | 4.96 | 3.90 | 0.02 (neg) | 0.78 |
|
| 313.76 | 4.37 | 3.71 | 0.34 (neg) | 1.17 |
|
| 1212.38 | 5.10 | 4.17 | 0.03 (neg) | 0.61 |
|
| 1882.68 | 4.96 | 4.87 | 0.75 (pos) | 1.03 |
|
| 2307.19 | 5.11 | 4.63 | 0.23 (neg) | 1.14 |
|
| 1733.09 | 4.14 | 4.20 | 0.30 (neg) | 1.51 |
|
| 725.86 | 4.99 | 4.10 | 0.01 (neg) | 0.79 |
|
| 418.02 | 4.31 | 3.90 | 0.37 (neg) | 1.21 |
|
| 1097.06 | 4.2 | 3.96 | 0.47 (neg) | 0.98 |
|
| 718.52 | 3.78 | 3.74 | 0.35 (neg) | 1.29 |
|
| 1187.42 | 4.21 | 4.83 | 0.57 (pos) | 1.06 |
|
| 320.31 | 4.12 | 3.69 | 0.50 (pos) | 1.22 |
|
| 695.39 | 3.87 | 4.43 | 0.46 (neg) | 0.83 |
|
| 190.96 | 4.41 | 5.60 | 0.61 (pos) | 1.61 |
|
| 1515.42 | 4.15 | 4.63 | 0.33 (neg) | 0.49 |
|
| 190.83 | 5.21 | 5.43 | 0.43 (neg) | 1.32 |
|
| 2158.86 | 4.85 | 5.31 | 0.08 (neg) | 1.18 |
|
| 100.83 | 5.27 | 5.87 | 0.54 (pos) | 1.92 |
|
| 451.79 | 4.91 | 5.34 | 0.39 (neg) | 1.29 |
|
| 139.64 | 5.00 | 5.68 | 0.57 (pos) | 1.43 |
|
| 749.5 | 5.17 | 6.34 | 0.49 (neg) | 0.85 |
a mg of compound per bodyweight of the rat required to kill half of a tested population; b negative logarithm (pIGC50) of the concentration (mol/L) of compound in water that causes 50% growth inhibition to Tetrahymena pyriformis after 48 h; c negative logarithm (pLC50) of the concentration (mol/L) of compound in water that kills half of fathead minnows (Pimephales promelas) in 96 h; d estimates mutagenicity of compound on Salmonella typhimuriu; e logarithmic value of ratio of the concentration of compound in the tissue of an aquatic organism to its concentration in water (in litres per kilogram of tissue).
The statistical results of QSAR models (1).
| Statistical Parameters | Model 1 |
|---|---|
|
| 23 |
|
| 9 |
|
| 0.78 |
|
| 0.75 |
|
| 0.03 |
|
| 23.46 |
|
| 0.20 |
| Δ | 0.12 |
|
| 0.02 |
|
| 0.02 |
|
| 0.88 |
|
| 0.67 |
|
| 0.03 |
|
| 0.02 |
|
| 0.82 |
|
| 0.14 |
|
| −0.28 |
|
| 0.09 |
|
| 0.03 |
|
| 0.02 |
|
| 0.67 |
|
| 0.81 |
|
| 0.62 |
|
| 0.61 |
|
| 0.68 |
| 0.54 | |
| 0.02 | |
| Applicability domain | |
| - | |
| - |
LOO (the leave-one out); R2 (coefficient of determination); R2adj (adjusted coefficient of determination); s (standard deviation of regression); F (Fisher ratio); Kxx (multivariate correlation index); ΔK (global correlation among descriptors); RMSE (root-mean-square error of the training set); MAE (mean absolute error of the training set); CCC (concordance correlation coefficient of the training set); Q2 (cross-validated explained variance); RMSE (root-mean-square error of the training set determined through the cross validated method; MAE (mean absolute error of the internal validation set); CCC (concordance correlation coefficient test set using cross validation); R2 (Y-scramble correlation coefficients); Q2 (Y-scramble cross-validation coefficients); RMSE (root-mean-square error of Y-randomization); RMSE (root-mean-square error of the external validation set); MAE (mean absolute error of the external validation set); R2 (coefficient of determination of validation set); Q21, Q22, Q23 (predictive squared correlation coefficients); CCC (concordance correlation coefficient of the test set); r2 average (average value of squared correlation coefficients between the observed and (leave-one-out) predicted values of the compounds with and without intercept); r2 difference (absolute difference between the observed and leave-one-out predicted values of the compounds with and without intercept); h* (warning leverage for the applicability domain of the model).
Correlation matrix (correlation coefficient, R) for the descriptors included in model (1).
|
|
|
| |
|---|---|---|---|
|
| 1.00 | ||
|
| −0.16 | 1.00 | |
|
| 0.29 | −0.22 | 1.00 |
Figure 1Williams plot of applicability domain of the QSAR model for inhibition of Macrophomina phaseolina calculated by model (1).
Figure 2Pharmacophore mapping of the most active compound 23 and of the least active compound 13 against pathogen fungi M. phaseolina. (Green = hydrogen-bond acceptor; Blue = hydrophobe region).
The statistical results of QSAR model (2).
| Statistical Parameters | Model 2 | Model 2a * |
|---|---|---|
|
| 28 | 28 |
|
| 10 ** | |
|
| 0.78 | 0.78 |
|
| 0.75 | 0.75 |
|
| 0.07 | 0.07 |
|
| 28.84 | 28.84 |
|
| 0.22 | 0.22 |
| Δ | 0.17 | 0.17 |
|
| 0.07 | 0.07 |
|
| 0.06 | 0.06 |
|
| 0.88 | 0.88 |
|
| 0.71 | 0.71 |
|
| 0.08 | 0.08 |
|
| 0.07 | 0.07 |
|
| 0.84 | 0.84 |
|
| 0.11 | 0.11 |
|
| −0.24 | −0.24 |
|
| 0.14 | 0.14 |
|
| 1.51 | |
|
| 1.44 | |
|
| 0.03 | |
|
| 0.01 | |
|
| −0.03 | |
|
| −9.06 | |
|
| −102.96 | |
| −0.21 | ||
| 0.47 | ||
| Applicability domain | ||
| 1 ( | 10 ( | |
| 1 ( | 2 ( | |
* model (2) applied to a test set containing previously excluded 10 low-active compounds (**).
Correlation matrix (correlation coefficient, R) for the descriptors included in model (2).
|
|
|
| |
|---|---|---|---|
|
| 1.00 | ||
|
| 0.20 | 1.00 | |
|
| 0.08 | 0.53 | 1.00 |
Figure 3Williams plot of applicability domain of the QSAR model for inhibition of Sclerotinia sclerotiorum calculated by model (2).
Figure 4Pharmacophore mapping of one of the most active compounds 8 and one of the least active compound 33 against pathogen fungi S. sclerotiorum. (Green = hydrogen-bond acceptor; Blue = hydrophobe region; Brown = hydrogen-bond donor).
Docking score energies (Total E/kcal mol−1) of interactions of the best ten docked poses of coumarin derivatives, including standard ligands * in complex with: demethylase (sterol 14α-demethylase (CYP51), pdb ID: 5eah); chitinase (pdb ID: 4txe); transferase (N-myristoyltransferase, pdb ID: 2p6g); endoglucanase I (pdb ID: 2ovw); proteinase K (pdb ID: 2pwb); pectinase (endopolygalacturonase, pdb ID: 1czf); AChE (acetylcholinesterase, pdb ID: 1eve.).
| Demethylase | Chitinase | Transferase | Endoglucanase I | Proteinase K | Pectinase | AChE | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Comp. | Total E | Comp. | Total E | Comp. | Total E | Comp. | Total E | Comp. | Total E | Comp. | Total E | Comp. | Total E |
| −100.41 | −122.83 | −99.82 | −127.50 | −114.21 | −96.65 | −118.95 | |||||||
| −96.19 | −121.58 | −93.73 | −123.92 | −114.07 | −89.25 | −112.30 | |||||||
| −86.71 | −115.99 | −91.27 | −113.50 | −110.68 | −86.21 | −107.19 | |||||||
| −86.05 | −115.37 | −88.30 | −107.84 | −109.91 | −84.93 | −106.67 | |||||||
| −85.79 | −112.76 | −85.82 | −105.32 | −109.92 | −84.49 | −105.41 | |||||||
| −84.84 | −112.29 | −84.52 | −104.68 | −107.92 | −84.14 | −104.48 | |||||||
| −84.18 | −110.99 | −84.51 | −104.19 | −104.19 | −81.44 | −104.32 | |||||||
| −81.35 | −110.43 | −83.12 | −104.11 | −104.13 | −81.19 | −103.03 | |||||||
| −81.14 | −109.87 | −82.71 | −104.07 | −103.34 | −80.92 | −102.67 | |||||||
| −80.10 | −107.96 | −82.32 | −102.75 | −102.34 | −80.27 | −101.18 | |||||||
* pdb ID of standard ligand.
The energies of the main interactions between proteinase K residues and compound 6.
| H Bond | Energy | Van der Waals Interaction | Energy |
|---|---|---|---|
| M-GLY-160 | −3.76 | S-HIS-69 | −1.28 |
| S-ASN-161 | −9.68 | M-SER-132 | −3.58 |
| M-SER-170 | −5.61 | M-LEU-133 | −8.08 |
| M-PRO-171 | −3.50 | M-GLY-134 | −10.23 |
| M-ALA-172 | −3.50 | M-GLY-135 | −4.94 |
| S-THR-223 | −2.50 | M-ALA-158 | −4.13 |
| M-SER-224 | −3.50 | M-ALA-159 | −6.16 |
| S-SER-224 | −4.71 | M-GLY-160 | −7.28 |
| M-ASN-161 | −3.49 | ||
| S-ASN-161 | −4.87 | ||
| S-ASN-162 | −2.68 | ||
| S-TYR-169 | −2.09 | ||
| M-SER-170 | −0.14 | ||
| M-SER-224 | −1.72 |
(M = main chain; S = side chain).
Figure 5The main interactions of compound 6 with residues in the binding site of proteinase K: (a) 3D representation of the binding site; (b) 2D representation of main interactions with interatomic distances (Å). (green = conventional hydrogen bond; light green = van der Waals; very light green carbon-hydrogen bond; purple = π–alkyl interactions).
Figure 6Hydrophobic surface representation of proteinase K active site with docked compound 6.